RUO‘ZENLog in
Stocks › Healthcare › GKOS

Glaukos stockGKOS

Glaukos Corp · NYSE
$219.98
−10.83% on the day
close Nov 5, 2026
What is happening with the stock

Glaukos trades at $219.98, 13.8% below its 52-week high (Nov 4, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +94.8% year to date, +160.8% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.

Why it is falling · −10.8% · Nov 5, 2026
  • Market pulseAI-led market rout drags Glaukos 9% lower despite no company-specific news during regular trading
All moves of the day →
Closing price, 6 monthsdetailed chart in the terminal
10117925852-week high 255.19May 8, 2026Nov 5, 2026
Reported figurestrailing 12 months
🔒 Sector comparison, estimates and ratings are in the terminal

Ratings, candles, signals and the screener for GKOS — after you log in

Open the terminal
From 52-week high−13.8%
High255.19 Nov 4, 2026
vs 50-day avg+24.0%
vs 200-day avg+53.0%
Year to date+94.8%
12 months+160.8%
Dividend yieldnone
EarningsFeb 25
Market cap$13.0B
Chart patterncup without handle
Exchange · sinceNYSE · 2015

Frequently asked questions about Glaukos

What is the Glaukos stock price?

At the close on Nov 5, 2026: $219.98 (−10.83% on the day). 52-week high: $255.19 on Nov 4, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Glaukos report earnings?

The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed +394% year over year, revenue +58%.

Does Glaukos pay dividends?

No, Glaukos does not pay dividends.

Where does Glaukos trade and how to buy it?

Ticker GKOS, exchange NYSE, listed since 2015. You can buy it through a broker with access to US exchanges.

Should I buy Glaukos now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for GKOS are in the terminal after you log in.

Similar stocks

More on GKOS

Included in lists